N. Ikebe

Multicenter Study of Pegylated Interferon α‐2a Monotherapy for Hepatitis C Virus‐Infected Patients on Hemodialysis: REACH Study

N. Hotta, N. Izumi, K. Nitta, 2014, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Induction of haem oxygenase-1 by nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth

H. Maeda, S. Shibahara, M. Ogawa, 1999, British Journal of Cancer.

Long-term control of secondary hyperparathyroidism by combination therapy with cinacalcet hydrochloride and intravenous active vitamin D

N. Terao, K. Yuasa, Hiroyuki Yamamoto, 2012 .

Effect of hemodiafiltration on acute hyperammonemia caused by disorder of the urea cycle

K. Nitta, T. Akiba, K. Kikuchi, 2007 .

Patterns in the prevalence of hepatitis C virus infection at the start of hemodialysis in Japan

K. Nitta, T. Akiba, K. Uchida, 2008, Clinical and Experimental Nephrology.

Protective effect of S-nitrosylated alpha(1)-protease inhibitor on hepatic ischemia-reperfusion injury.

H. Maeda, Y. Miyamoto, T. Akaike, 2000, The Journal of pharmacology and experimental therapeutics.

Novel functions of human alpha(1)-protease inhibitor after S-nitrosylation: inhibition of cysteine protease and antibacterial activity.

H. Maeda, Y. Miyamoto, T. Akaike, 2000, Biochemical and biophysical research communications.

Heme oxygenase and nitric oxide synthase on tumor growth

H. Maeda, M. Ogawa, T. Akaike, 2003 .